[go: up one dir, main page]

GB9314271D0 - Cell growth factor receptors - Google Patents

Cell growth factor receptors

Info

Publication number
GB9314271D0
GB9314271D0 GB939314271A GB9314271A GB9314271D0 GB 9314271 D0 GB9314271 D0 GB 9314271D0 GB 939314271 A GB939314271 A GB 939314271A GB 9314271 A GB9314271 A GB 9314271A GB 9314271 D0 GB9314271 D0 GB 9314271D0
Authority
GB
United Kingdom
Prior art keywords
growth factor
cell growth
factor receptors
receptors
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB939314271A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institute of Cancer Research Royal Cancer Hospital
Original Assignee
Institute of Cancer Research Royal Cancer Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute of Cancer Research Royal Cancer Hospital filed Critical Institute of Cancer Research Royal Cancer Hospital
Priority to GB939314271A priority Critical patent/GB9314271D0/en
Publication of GB9314271D0 publication Critical patent/GB9314271D0/en
Priority to AU70810/94A priority patent/AU7081094A/en
Priority to ZA944983A priority patent/ZA944983B/en
Priority to PCT/GB1994/001480 priority patent/WO1995002187A1/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G01N33/5759
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/136Screening for pharmacological compounds
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/91Transferases (2.)
    • G01N2333/912Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
GB939314271A 1993-07-09 1993-07-09 Cell growth factor receptors Pending GB9314271D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GB939314271A GB9314271D0 (en) 1993-07-09 1993-07-09 Cell growth factor receptors
AU70810/94A AU7081094A (en) 1993-07-09 1994-07-08 Cell growth factor receptors
ZA944983A ZA944983B (en) 1993-07-09 1994-07-08 Cell growth factor receptors
PCT/GB1994/001480 WO1995002187A1 (en) 1993-07-09 1994-07-08 Cell growth factor receptors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939314271A GB9314271D0 (en) 1993-07-09 1993-07-09 Cell growth factor receptors

Publications (1)

Publication Number Publication Date
GB9314271D0 true GB9314271D0 (en) 1993-08-18

Family

ID=10738572

Family Applications (1)

Application Number Title Priority Date Filing Date
GB939314271A Pending GB9314271D0 (en) 1993-07-09 1993-07-09 Cell growth factor receptors

Country Status (4)

Country Link
AU (1) AU7081094A (en)
GB (1) GB9314271D0 (en)
WO (1) WO1995002187A1 (en)
ZA (1) ZA944983B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6051397A (en) * 1993-11-16 2000-04-18 Max Planck Gesellschaft Zur Forderung Der Wissenschaften DNA encoding MCK-10, a novel receptor tyrosine kinase
US5911995A (en) * 1994-08-19 1999-06-15 Regents Of The University Of Minnesota EGF-genistein conjugates for the treatment of cancer
US5587459A (en) * 1994-08-19 1996-12-24 Regents Of The University Of Minnesota Immunoconjugates comprising tyrosine kinase inhibitors
FR2780161B1 (en) * 1998-06-17 2000-09-29 Centre Nat Rech Scient METHOD FOR EARLY DIAGNOSIS OF CANCER BASED ON THE SEARCH FOR AUTO-ANTIBODIES DIRECTED AGAINST THE CSK PROTEIN AND KIT FOR ITS IMPLEMENTATION
SI1454992T1 (en) * 2003-03-07 2006-10-31 Ist Naz Stud Cura Dei Tumori Anaplastic lymphoma kinase assay, reagents and compositions thereof
DK2006381T3 (en) 2006-03-31 2016-02-22 Chugai Pharmaceutical Co Ltd PROCEDURE FOR REGULATING ANTIBODIES BLOOD PHARMACOKINETICS
DK2202245T3 (en) 2007-09-26 2016-11-21 Chugai Pharmaceutical Co Ltd A method of modifying an antibody isoelectric point VIA amino acid substitution in CDR
UA121453C2 (en) 2008-04-11 2020-06-10 Чугей Сейяку Кабусікі Кайся METHOD OF PREPARATION OF PHARMACEUTICAL COMPOSITION CONTAINING ANTIBODY
KR102385507B1 (en) 2010-11-30 2022-04-12 추가이 세이야쿠 가부시키가이샤 Antigen-binding molecule capable of binding to plurality of antigen molecules repeatedly
CA2827923C (en) 2011-02-25 2021-11-23 Chugai Seiyaku Kabushiki Kaisha Fc.gamma.riib-specific fc antibody
EP2518157A1 (en) 2011-04-26 2012-10-31 Sanofi Test Systems and methods for identifying a compound altering cellular DDR activity
JP6101205B2 (en) 2011-08-23 2017-03-22 中外製薬株式会社 Novel anti-DDR1 antibody having antitumor activity
TW201817745A (en) 2011-09-30 2018-05-16 日商中外製藥股份有限公司 Therapeutic antigen-binding molecule having an FcRn binding domain that promotes antigen clearance
JP6322411B2 (en) 2011-09-30 2018-05-09 中外製薬株式会社 Antigen-binding molecules that promote the disappearance of antigens with multiple physiological activities
SG10201609301QA (en) 2011-11-30 2016-12-29 Chugai Pharmaceutical Co Ltd Drug containing carrier into cell for forming immune complex
SG10201704849PA (en) 2012-02-09 2017-07-28 Chugai Pharmaceutical Co Ltd Modified fc region of antibody
AU2013306700B2 (en) 2012-08-24 2019-05-02 Chugai Seiyaku Kabushiki Kaisha FcgammaRIIb-specific Fc region variant
WO2014163101A1 (en) 2013-04-02 2014-10-09 中外製薬株式会社 Fc region variant

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8900529A (en) * 1989-03-03 1990-10-01 Eurodiagnostics B V METHOD AND KIT FOR DETERMINING TYROSINE PHOSPHORYLATING AND DEPHOSPHORLING ACTIVITY.
CA2062377A1 (en) * 1991-03-21 1992-09-22 Mariano Barbacid Method for detection of neuroactive substances

Also Published As

Publication number Publication date
AU7081094A (en) 1995-02-06
ZA944983B (en) 1996-01-08
WO1995002187A1 (en) 1995-01-19

Similar Documents

Publication Publication Date Title
GB9125623D0 (en) Cell modification
ZA935284B (en) Photovoltaic cell
IL125126A0 (en) Electroconversion cell
TW441662U (en) Cell material structure
EP0534416A3 (en) Solar cell
GB9314271D0 (en) Cell growth factor receptors
EP0534473A3 (en) Solar cell
AU4410893A (en) Electrolytic cell
EP0537730A3 (en) Solar cell
GB9311252D0 (en) Cell growth regualtors
ZA914783B (en) Mast cell growth factor
GB9206732D0 (en) Photovoltaic cells
SG52238A1 (en) Haemopoietic growth factor antagonists
IL102374A0 (en) Nanocrystalline cell
IL96902A0 (en) T cell growth factor
GB9225928D0 (en) Growth factor
GB9424232D0 (en) Growth factor expression
GB9107612D0 (en) Cell culture
GB9309833D0 (en) Artificial flower arrangement
EP0891372A4 (en) Growth factor htter36
GB9425050D0 (en) Cell line
GB9225776D0 (en) Cell line
GB9213256D0 (en) Cell
GB9318528D0 (en) Cell line
GB9306945D0 (en) Cell modification